Israeli Nurami Medical Secures $30M to Expand Neuro-Surgical Innovations
Amir Bahar, Nurami Medical Founder
Israel-based biomedical company Nurami Medical has raised US$30 million in its latest funding round.
The funds will help expand its workforce and scale operations, including the construction of a commercial manufacturing facility, research and development lab, and clean rooms for producing its first FDA-approved product.
Nurami develops products for neurological surgeries, specifically addressing cerebrospinal fluid leakage.
Founded in 2014 by Nora Nseir and Dr. Amir Bahar, the company recently received regulatory approval for a nanofiber-based surgical patch designed to support post-surgical recovery by naturally degrading and integrating into the body.
Source: Tech in Asia
Nurami Medical
Nurami Medical, is an early commercial stage company revolutionizing next-generation surgical products for the repair, regeneration, and safe healing of soft tissues following internal surgeries, based on unique formulations of biomaterials and electrospun nanofiber-based bio-mimetic scaffolds.